Anti-glycoprotein antibody development involves generating monoclonal antibodies that specifically recognize glycoproteins for research, diagnostic, or therapeutic use. Techniques like phage display, hybridoma technology, and antigen-specific B cell sorting enable high-affinity antibody discovery. These antibodies are crucial for studying glycosylation-related functions, targeting disease biomarkers, and advancing precision medicine through tailored immunotherapies and glycan-specific diagnostics.
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek